We welcome your views on our website and invite you to take part in a brief survey when you've finished your visit.
Your response will help us improve the site and the experience we offer to visitors.
Some of the principal treatments carried out by Miss Michelle Mullan at Spire include:
I qualified from the University of Bristol in 1995, since then I have undergone extensive training in both the UK and United States in Oncoplastic Breast Surgery. I became a Fellow of the Royal College of Surgeons (England) in 2006. In 2008, I won the European Society of Breast Cancer Specialists Travelling Scholarship and spent my time at the Nottingham Breast Institute. I was appointed as an Oncoplastic Breast Consultant at Worcestershire Royal Hospital in 2008 and I was Breast Lead for the county for 10 years. In 2018 I became Clinical Lead for all Cancer Services for the county.
In 2019 I moved to North Bristol NHS Trust to join the Breast Service, based at Southmead Hospital. I am a Trustee for the Association of Breast Surgery and sit on the Clinical Practices and Standards Committee.
My interests include breast cancer surgery using Oncoplastic techniques, sentinel lymph node biopsy, lipofilling of breast defects (fat transfer), breast reconstruction, nipple reconstruction and nipple tattooing. I am a fully trained breast screening surgeon for the NHS Breast Screening Programme. I am also interested in benign breast work (such as breast pain and nipple discharge) and I enjoy treating teenage girls with breast problems.
Special clinical interests: Oncoplastic breast and reconstructive surgery; Sentinel node biopsy; Colman fat transfer; Breast ultrasound.
North Bristol NHS TrustBack to top
|Private secretary||Emma Smyth|
|Private secretary telephone||0117 933 9982|
|Private secretary email@example.com|
11 February 2020
Redbridge-based Spire London East Hospital has been upgraded to a ‘Good’ rating following an inspection by the Care Qual…
04 February 2020
The Paterson Independent Inquiry published its final report on 4 February 2020.